These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32865353)

  • 21. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased placenta growth factor mRNA level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
    Cheng SJ; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Chiang ML; Kuo MY
    J Formos Med Assoc; 2013 May; 112(5):253-8. PubMed ID: 23660220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
    Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
    Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-196a overexpression and miR-196a2 gene polymorphism are prognostic predictors of oral carcinomas.
    Liu CJ; Tsai MM; Tu HF; Lui MT; Cheng HW; Lin SC
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S406-14. PubMed ID: 23138850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study.
    Nakashima H; Yoshida R; Hirosue A; Kawahara K; Sakata J; Arita H; Yamamoto T; Toya R; Murakami R; Hiraki A; Shinohara M; Ito T; Kuwahara Y; Nakayama H
    Tumour Biol; 2019 Mar; 41(3):1010428319826853. PubMed ID: 30887897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTEN and miR-26b: Promising prognostic biomarkers in initiation and progression of Oral Squamous Cell Carcinoma.
    Baghaei F; Abdollahi A; Mohammadpour H; Jahanbin M; Naseri Taheri F; Aminishakib P; Emami Razavi A; Kharazifard M
    J Oral Pathol Med; 2019 Jan; 48(1):31-35. PubMed ID: 30372795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
    Cui Y; Xue Y; Dong S; Zhang P
    J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular vesicles miR-210 as a potential biomarker for diagnosis and survival prediction of oral squamous cell carcinoma patients.
    Bigagli E; Locatello LG; Di Stadio A; Maggiore G; Valdarnini F; Bambi F; Gallo O; Luceri C
    J Oral Pathol Med; 2022 Apr; 51(4):350-357. PubMed ID: 34800057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-29b regulates migration in oral squamous cell carcinoma and its clinical significance.
    Yang CN; Deng YT; Tang JY; Cheng SJ; Chen ST; Li YJ; Wu TS; Yang MH; Lin BR; Kuo MY; Ko JY; Chang CC
    Oral Oncol; 2015 Feb; 51(2):170-7. PubMed ID: 25435433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma.
    Shi J; Bao X; Liu Z; Zhang Z; Chen W; Xu Q
    Theranostics; 2019; 9(4):920-931. PubMed ID: 30867806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of hypoxia-inducible factor 1α is associated with lymph node metastasis in oral squamous cell carcinoma].
    Li JN; Feng ZE; Wang L; Wang YX; Guo CB
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 50(1):26-32. PubMed ID: 29483718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
    Wang WT; Guo CQ; Cui GH; Zhao S
    World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression level of extracapsular spread and tumor budding for cervical lymph node metastasis of OSCC.
    Yamada SI; Otsuru M; Yanamoto S; Hasegawa T; Aizawa H; Kamata T; Yamakawa N; Kohgo T; Ito A; Noda Y; Hirai C; Kitamura T; Okura M; Kirita T; Ueda M; Yamashita T; Ota Y; Komori T; Umeda M; Kurita H
    Clin Oral Investig; 2018 Apr; 22(3):1311-1318. PubMed ID: 28986696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive Prognostic Value of Tissue-Based MicroRNA Expression in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
    Troiano G; Mastrangelo F; Caponio VCA; Laino L; Cirillo N; Lo Muzio L
    J Dent Res; 2018 Jul; 97(7):759-766. PubMed ID: 29533734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma.
    Chang CC; Yang YJ; Li YJ; Chen ST; Lin BR; Wu TS; Lin SK; Kuo MY; Tan CT
    Oral Oncol; 2013 Sep; 49(9):923-931. PubMed ID: 23602254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
    Jiang T; Xie P; Liu H
    J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of Naa10p associates with lymph node metastasis and predicts favorable prognosis of oral squamous cell carcinoma.
    Zeng Y; Zheng J; Zhao J; Jia PR; Yang Y; Yang GJ; Ma JF; Gu YQ; Xu J
    Tumour Biol; 2016 May; 37(5):6719-28. PubMed ID: 26662107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-610 functions as a tumor suppressor in oral squamous cell carcinoma by directly targeting AGK.
    Yao LX; Liu J; Xu L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):187-197. PubMed ID: 30657560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
    Kono M; Watanabe M; Abukawa H; Hasegawa O; Satomi T; Chikazu D
    J Oral Maxillofac Surg; 2013 Oct; 71(10):1694-702. PubMed ID: 23809761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma.
    Pedersen NJ; Jensen DH; Lelkaitis G; Kiss K; Charabi BW; Ullum H; Specht L; Schmidt AY; Nielsen FC; von Buchwald C
    Oral Oncol; 2018 Aug; 83():46-52. PubMed ID: 30098778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.